SleepCited

Integrative Approaches in the Treatment of Patients Affected by Lymphoma.

Ilana Levy Yurkovski, Francesca Andreazzoli, Eran Ben-Arye, Samuel Attias, Tamar Tadmor
Review Current oncology reports 2023 5 件の引用

研究デザイン

研究タイプ
Review
対象集団
Review of complementary and integrative medicine modalities for patients with lymphoma across disease stages (prevention, active treatment, survivorship, palliative care). Modalities reviewed include low inflammatory diet, ginseng, acupuncture, vitamin D, curcumin, and herbal medicines.
介入
Integrative Approaches in the Treatment of Patients Affected by Lymphoma. None
比較対照
No treatment / standard care
主要アウトカム
Efficacy and safety of complementary and integrative medicine (CIM) modalities in lymphoma management
効果の方向
Positive
バイアスリスク
Unclear

抄録

PURPOSE OF REVIEW: Lymphoma is the most frequent hematological malignancy with wide disease spectrum of watchful waiting period, active treatment, survivorship, and palliative care. All these steps impose unmet needs in terms of prevention, symptom alleviation, or prognosis. Complementary and integrative medicine (CIM) is widely used by patients with lymphoma to cope with such issues. Here, we describe the different CIM modalities that may be effective and safe for the management of patients with lymphoma. RECENT FINDINGS: Low inflammatory diet and ginseng seem effective for lymphoma prevention. Pain and neuropathy may be improved using acupuncture, touch therapy and specific dietary supplements. Nausea/vomiting, fatigue, and insomnia may be relieved by acupuncture, mind-body, touch therapy, and certain dietary supplements. Vitamin D, curcumin, and some traditional medicine herbs may positively impact lymphoma prognosis. Finally, safety issues should be considered especially for the concomitant use of dietary supplements and lymphoma-directed therapies. CIM may be beneficial along the continuum of lymphoma management although safety concerns should be considered when used concomitantly with conventional therapy.

要約

Different CIM modalities may be beneficial along the continuum of lymphoma management although safety concerns should be considered when used concomitantly with conventional therapy.

エビデンスレビューでの引用